Microsphere-based Biodegradable Implant
Description: A combination of microspheres and biodegradable polymer scaffolding to form a biodegradable implant.
Product Details
User: Female
Hormonal: Yes
Delivery Method: Subdermal
Duration Type: Long-acting
Duration: 18 months
Regimen: - Single administration every 18 months
- Single administration every 18 months
Active Pharmaceutical Ingredient (API): - levonorgestrel
- levonorgestrel
Multipurpose Preventive Technology (MPT): Yes
Status Details
Developer: FHI 360, University of Washington
Project Phase: Pre-Clinical and Clinical Development
Development Stage: Pre-clinical
Began discovery in: 2015
Active Development: No
Additional Information
References: University of Washington Portfolio Website: https://bioe.uw.edu/portfolio-items/bratner/
University of Washington Portfolio Website: https://bioe.uw.edu/portfolio-items/bratner/